INS and obstructive sleep apnea syndrome: Overall, the downregulation of miRNA-181a observed in OSA may mean that non-OSA patients are more resistant to developing diabetic-related cardiomyopathy or nephropathy, but have less expanded compensatory mechanisms against impaired insulin sensitivity.